GSK PLC (GSK) is a Zacks Rank #5 (Strong Sell) after the company beat the Zacks Consensus Estimate when the last reported. The company is in the healthcare space and there has been a lot of press ...
Stockhead on MSN22h
Biocurious: Consumer health minnow Wellnex Life gears up for company-making EurotripWellnex is undertaking a $16 million capital raising ahead of a dual listing on London's AIM exchange, a focal point ... Read ...
Even as GSK’s RSV vaccine launch hits a serious slowdown, the British pharma has dialed up its long-term sales guidance once ...
GSK plans to buy back £2 billion (S$3.4 billion) of shares as it raised its long-term growth outlook on optimism around its ...
To understand how the Mayo Clinic became a superior healthcare brand, I talked with Leonard Berry, PhD, to understand their ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback